Advertisement

Topics

FDA cracks down on abuse of patient-protection program

06:21 EDT 28 Jul 2017 | SmartBrief

Some makers of brand name drugs have taken advantage of the FDA's Risk Evaluation and Mitigation Strategies program, which is -More

Original Article: FDA cracks down on abuse of patient-protection program

NEXT ARTICLE

More From BioPortfolio on "FDA cracks down on abuse of patient-protection program"

Quick Search
Advertisement
 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...